Trinity Biotech plc

NASDAQ:TRIB

Medical - Diagnostics & Research

Healthcare
$5.83 -5.73%

-$0.51 today

Market cap
$117.96M
Beta
1.00
P/E (TTM)
-0.1
EPS (TTM)
-$60.27
52W Low $8.00High $103.20

Volume 0.00M

Average 1.34M

Cash Flow

Check whether earnings turn into cash.

Operating Cash Flow

-$5.93M

FY 2025 · Annual

Investing Cash Flow

-$6.22M

FY 2025 · Annual

Financing Cash Flow

$12.05M

FY 2025 · Annual

-58.2% YoY

Cash Flow Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income875K(41.01M)(24.02M)(31.79M)(37.38M)
Depreciation & Amortization2.74M2.33M1.78M1.87M2.68M
Deferred Income Tax(167K)(192K)(59K)486K199K
Stock-Based Compensation1.1M1.76M2.07M1.32M324K
Change in Working Capital(172K)(1.66M)(2.69M)6.19M7.03M
Accounts Receivables6.24M(966K)1.05M(2.37M)4.92M
Inventory(4.41M)(877K)(971K)(1.74M)90K
Accounts Payables(7.59M)181K(2.77M)8.19M0
Other Working Capital5.59M7.57M(478K)10.3M2.02M
Other Non-Cash Items8.86M37.85M11.37M17.74M21.21M
Operating Cash Flow13.24M(921K)(11.56M)(4.19M)(5.93M)
Capital Expenditures(8.69M)(5.98M)(803K)(10.06M)(6.22M)
Acquisitions (Net)0028.16M(12.9M)0
Purchases of Investments00(700K)00
Sales of Investments00000
Other Investing Activities(6.88M)(4.88M)(1.9M)(9.66M)(6.14M)
Investing Cash Flow(8.69M)(5.98M)24.76M(22.97M)(6.22M)
Debt Repayment(2.94M)(27.04M)(7.37M)27.67M11.81M
Common Stock Issued025.34M07.39M547K
Common Stock Repurchased00000
Dividends Paid00000
Other Financing Activities(3.08M)(10.61M)(8.67M)(6.25M)(308K)
Financing Cash Flow(6.02M)(12.32M)(16.04M)28.81M12.05M
Effect of Forex Changes55K(112K)(44K)(175K)71K
Net Change in Cash(1.42M)(19.33M)(2.89M)1.48M(29K)
Free Cash Flow4.55M(6.9M)(12.36M)(14.26M)(12.15M)

Free Cash Flow

Net Income to FCF bridge

FY2025

= Net Income-$37.4M
+ D&A$2.7M
+ Stock-Based Comp$324.0K
+ Deferred Tax$199.0K
+ Working Capital$7.0M
+ Other Non-Cash$21.2M
= Operating Cash Flow-$5.9M
- Capex-$6.2M
= Free Cash Flow-$12.2M

Analysis

FY2025 free cash flow is -$12.2M. FCF conversion is 32.5% of net income. Operating cash flow was -$5.9M, with capex of -$6.2M. The largest bridge item is Other Non-Cash at $21.2M.

Competitors

Peer companies in the same sector

Health

No competitor data available.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
6-K6-K filingNov 12, 2026
SC 13D/ASC 13D/A filingNov 10, 2026
6-K6-K filingOct 5, 2026
6-K6-K filingSep 9, 2026
6-K6-K filingSep 8, 2026

Does TRIB generate free cash flow?

Trinity Biotech plc (TRIB) generated -$12.15M of free cash flow in fiscal 2025.

How much operating cash flow does TRIB produce?

Operating cash flow was -$5.93M, before capital expenditures of $6.22M.